Matches in Wikidata for { <http://www.wikidata.org/entity/Q90773822> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q90773822 description "articolo scientifico (pubblicato il 2019)" @default.
- Q90773822 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q90773822 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q90773822 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90773822 description "scientific article published on 01 February 2019" @default.
- Q90773822 description "wetenschappelijk artikel" @default.
- Q90773822 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q90773822 name "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 name "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 name "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 type Item @default.
- Q90773822 label "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 label "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 label "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 prefLabel "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 prefLabel "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 prefLabel "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 P1433 Q90773822-FBCA0874-C392-4879-9883-33CA4BE9ADA8 @default.
- Q90773822 P1476 Q90773822-62785E63-9F78-4F32-B451-DB686DBAAE5D @default.
- Q90773822 P2093 Q90773822-137CD819-BA10-49D4-809E-A6A869D7371C @default.
- Q90773822 P2093 Q90773822-4451168D-7D09-4277-8F5E-D42A4660F3EF @default.
- Q90773822 P2093 Q90773822-8A4018B7-87E4-4448-9B46-4082F174863D @default.
- Q90773822 P2093 Q90773822-92BEE3AA-1D45-4603-81ED-87F6A65088CA @default.
- Q90773822 P2093 Q90773822-AB55B488-0D8F-4288-A6B9-EA23450F515D @default.
- Q90773822 P2093 Q90773822-B58830F6-1E24-44F1-BC67-E57E6B862178 @default.
- Q90773822 P2093 Q90773822-C9E8F7FE-6B2A-4150-9540-944DC4198172 @default.
- Q90773822 P2093 Q90773822-D5CA7C28-BE6F-455C-B0E8-ED73DCFEE119 @default.
- Q90773822 P2093 Q90773822-FB64C429-065E-47A6-9510-D4CCE5879D7B @default.
- Q90773822 P304 Q90773822-DEDA4267-E2EA-4D18-ACCF-F4AB66D36481 @default.
- Q90773822 P31 Q90773822-469317B1-7ED2-408C-BFA5-27DB1602F6D8 @default.
- Q90773822 P356 Q90773822-A38D8ADE-CB15-4B67-8111-E0CD313843AF @default.
- Q90773822 P433 Q90773822-8682B8BD-3498-4547-B659-A4A5C7BED860 @default.
- Q90773822 P478 Q90773822-43F1E4EA-BA62-48EC-BF3D-7BBD4C99198E @default.
- Q90773822 P50 Q90773822-36C40EDA-6173-4667-883A-40041D7FAC70 @default.
- Q90773822 P50 Q90773822-8A3CF1DD-2D68-4E96-8F53-F2D323D002E1 @default.
- Q90773822 P577 Q90773822-DA65C72D-D6CF-4403-83D4-6480E8A25227 @default.
- Q90773822 P698 Q90773822-9AEA3185-386A-461F-B694-96C8D8F7C366 @default.
- Q90773822 P921 Q90773822-1BF05B96-0556-4103-B7D8-7513F80A0A9B @default.
- Q90773822 P921 Q90773822-F6743253-3E1C-4546-B7F0-378316009D09 @default.
- Q90773822 P932 Q90773822-86FBE40C-976E-438E-8E1A-6D2ED184AF53 @default.
- Q90773822 P356 HEPR.13300 @default.
- Q90773822 P698 30589492 @default.
- Q90773822 P1433 Q15752035 @default.
- Q90773822 P1476 "Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials" @default.
- Q90773822 P2093 "Hitoshi Yoshiji" @default.
- Q90773822 P2093 "Ikuya Sato" @default.
- Q90773822 P2093 "Kazuyuki Suzuki" @default.
- Q90773822 P2093 "Kiwamu Okita" @default.
- Q90773822 P2093 "Masaki Fujisawa" @default.
- Q90773822 P2093 "Masatoshi Imamura" @default.
- Q90773822 P2093 "Mikio Yanase" @default.
- Q90773822 P2093 "Naoya Murashima" @default.
- Q90773822 P2093 "Tetsuya Mine" @default.
- Q90773822 P304 "404-418" @default.
- Q90773822 P31 Q13442814 @default.
- Q90773822 P356 "10.1111/HEPR.13300" @default.
- Q90773822 P433 "4" @default.
- Q90773822 P478 "49" @default.
- Q90773822 P50 Q114923480 @default.
- Q90773822 P50 Q88185964 @default.
- Q90773822 P577 "2019-02-01T00:00:00Z" @default.
- Q90773822 P698 "30589492" @default.
- Q90773822 P921 Q42824440 @default.
- Q90773822 P921 Q642548 @default.
- Q90773822 P932 "6849579" @default.